Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
National Institute of Child Health and Human Development
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
Phillip Kasirye, Michael Kawooya, Amelia K. Boehme, Nancy Green et al.
Citations
5 citations
Journal
Contemporary Clinical Trials Communications
Topics
Hemoglobinopathies and Related Disorders
Field-Weighted Citation Impact (FWCI)
2.19
article
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
Phillip Kasirye, Michael Kawooya, Amelia K. Boehme, Nancy Green, Ezekiel Mupere, Richard Idro, Frank J. Minja, Deogratias Munube, John M. Ssenkusu, Robert Opoka, Vincent Mboizi, Caterina Rosano, Catherine Nabaggala, Samson Kamya
Emory University (US), Columbia University Irving Medical Center (US), Mengo Hospital (UG), World Health Organization - Uganda (UG), University of Pittsburgh Medical Center (US), Makerere University (UG)
Funders
National Institutes of Health, Fogarty International Center, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial — Phillip Kasirye, Michael Kawooya, et al. · Contemporary Clinical Trials Communications (2024) | TGRS Research Map | TGRS